PTC Therapeutics Inc (NASDAQ:PTCT)

73.46
Delayed Data
As of Feb 26
 -0.13 / -0.18%
Today’s Change
14.51
Today|||52-Week Range
74.93
+41.90%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

--
Revenue and IncomeNet Revenues105.4M33.9M34.7M--
 
 
 
 
Depreciation And Amortization2.9M2.7M2.4M--
 
 
 
 
 
Operating ExpensesGross Income--31.2M----
 
 
General Expenses72.0M58.1M77.7M--
 
 
 
 
Research And Development58.7M46.1M54.9M--
 
 
 
 
Total Operating Expenses74.8M60.8M80.1M--
 
 
 
 
 
Non-Operating ExpensesOperating Income30.6M-26.8M-45.4M--
 
 
 
 
Extraordinary Credit----37.5K--
 
 
Extraordinary Charge-----130.0K--
 
 
Interest Expense On Debt2.4M1.2M6.1M--
 
 
 
 
Other Expenses461.4K1.8M0.00--
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income28.6M-26.2M-51.6M--
 
 
 
 
Income Taxes-2.3M0.000.00--
 
 
Preferred Dividend0.000.00-18.2M--
 
 
Net Income30.9M133.3M-48.2M--
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS14.2M14.2M12.8M--
 
 
 
 
Shares To Calculate EPS Diluted14.2M14.2M12.8M--
 
 
 
 
 
Earnings Per ShareEPS--$9.40-$5.18--
 
 
 
EPS Diluted$2.18$9.40-$5.18--
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account